|
Q3 2017
Filed on Nov 14, 2017
|
10,814
|
$72.53 - $118.27
$784K - $1.28M
|
|
Tetraphase Pharmaceuticals I
|
Q3 2017
Filed on Nov 14, 2017
|
161,403
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
14,419
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
1,000
|
$94.75 - $104.34
$94.8K - $104K
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
1,500
|
$82.77 - $90.49
$124K - $136K
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
22,592
|
$80.6 - $94.95
$1.82M - $2.15M
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
67,500
|
$94.75 - $104.34
$6.4M - $7.04M
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
7,209
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
53,000
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
50,468
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
28,351
|
$18.0 - $22.52
$510K - $638K
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
71,799
|
$18.9 - $28.2
$1.36M - $2.02M
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
120,956
|
$7.55 - $10.05
$913K - $1.22M
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
39,000
|
$69.95 - $85.8
$2.73M - $3.35M
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
24,586
|
$42.01 - $49.32
$1.03M - $1.21M
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
2,000
|
$41.08 - $44.09
$82.2K - $88.2K
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
99,944
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
14,418
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
90,000
|
$18.25 - $22.43
$1.64M - $2.02M
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
7,210
|
$39.62 - $46.17
$286K - $333K
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
7,212
|
$230.77 - $258.75
$1.66M - $1.87M
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
42,330
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
72,147
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
36,046
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
61,071
|
$20.29 - $29.88
$1.24M - $1.82M
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
108,435
|
$5.4 - $8.47
$586K - $918K
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
72,091
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
2,500
|
N/A
|
|